Relevant conflicts of interest/financial disclosures: Nothing to report. Full financial disclosures and author roles can be found in the online version of this article.
Putaminal, but not nigral alterations, characterize hemiparkinsonism-hemiatrophy syndrome: A case report†
Version of Record online: 13 OCT 2010
Copyright © 2010 Movement Disorder Society
Volume 26, Issue 2, pages 352–354, 1 February 2011
How to Cite
Pisani, V., Stanzione, P., Meschini, A., Marziali, S., Garaci, F. G., Brancati, F., Nicoletti, A., Zappia, M. and Pisani, A. (2011), Putaminal, but not nigral alterations, characterize hemiparkinsonism-hemiatrophy syndrome: A case report. Mov. Disord., 26: 352–354. doi: 10.1002/mds.23357
- Issue online: 14 MAR 2011
- Version of Record online: 13 OCT 2010
- Ministero Salute (Progetto Finalizzato)
Additional Supporting information may be found in the online version of this article.
|MDS_23357_sm_suppinfoFigure_S1.tif||1192K||Supporting Information Figure S1: Brain MRI Flair T2-weight sequences in HPHA patient (A-D): all the slices demonstrate the apparent absence of structural brain abnormalities.|
|Figure_S2.tif||797K||Supporting Information Figure S2: Vertical point-plots show distribution of all measured FA values of HPHA case (black circles) and healthy subjects (white circles) in substantia nigra (A), putamen (B), globus pallidus (C), caudate (D), thalamus (E), subthalamic nucleus (F), corticospinal tract in internal capsule (G) and in cerebral peduncle (H). In (I) we showed mean diffusivity values in basal ganglia and other brain areas measured in HPHA patient (black circles) and in control group subjects (white circles).|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.